Cartiva’s FDA Win for Approval of First Synthetic Cartilage Signals Change for Orthopedics

MT035_Podcast_Facebook

EPISODE 035

Cartiva secured an historic win when the FDA approved its synthetic cartilage. CEO Tim Patrick explains what it took to get the approval and how the company will sell going forward.

Podcast Guest

Timothy-Patrick

Timothy Patrick

President and CEO

Cartiva

Tim is the President, Chief Executive Officer and co-founder of Cartiva. Tim has over 30 years of successful leadership experience in general management and product commercialization in the medical device industry. Prior to founding Cartiva, Tim was President and CEO of Proxima Therapeutics, Inc., a medical device company that developed and marketed innovative local radiation delivery systems for the treatment of solid cancerous tumors. Proxima was acquired by Cytyc Corporation in March 2005.

Prior to co-founding Proxima Therapeutics in 1996, Tim was President of Gesco International, the leading manufacturer of peripherally inserted central venous catheters, acquired by C.R. Bard. Before serving as President of Gesco International, he ran two high growth divisions for McGaw Inc., an infusion equipment and drug delivery company which was acquired by B. Braun. He also held a number of sales and sales management positions at American Hospital Supply Corporation.

Tim has served on the Board of Directors of the Advanced Medical Technology Association (AdvaMed), the Board of the Georgia Tech Coulter Grant Committee and on the Board of Georgia Bio. Tim is an inventor on a number of medical device patents. He earned his BA in Zoology from Miami University in Ohio.

Do You Have

A STORY TO TELL?

If you’d like to be considered as a guest on a future episode of the Medtech Talk Podcast, please complete the application today.

Meet Our Host

Geoff Pardo

Geoff-Pardo

Geoff has been in medtech for over two decades in both operational and investment roles. He is passionate about the industry potential and sharing stories from the front lines of innovation.

Subscribe

ON iTUNES

Don't miss an episode. Join the conversation by visiting our podcast channel on iTunes today and subscribe. It's fast and free!